Secondary prevention of ischaemic cardiac events


Secondary prevention in this context is the long-term treatment to prevent recurrent cardiac morbidity and mortality, and to improve quality of life in people who had either a prior MI or acute coronary syndrome, or who are at high risk of ischaemic cardiac events for other reasons, such as severe coronary artery stenoses or prior coronary surgical procedures.

Latest citations

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. (09 April 2014)

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. (25 February 2014)